1. Home
  2. WRAP vs ACET Comparison

WRAP vs ACET Comparison

Compare WRAP & ACET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wrap Technologies Inc.

WRAP

Wrap Technologies Inc.

HOLD

Current Price

$2.78

Market Cap

111.3M

Sector

Industrials

ML Signal

HOLD

Logo Adicet Bio Inc.

ACET

Adicet Bio Inc.

HOLD

Current Price

$8.23

Market Cap

71.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRAP
ACET
Founded
2016
1947
Country
United States
United States
Employees
N/A
N/A
Industry
Ordnance And Accessories
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
111.3M
71.3M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WRAP
ACET
Price
$2.78
$8.23
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$96.67
AVG Volume (30 Days)
432.3K
199.8K
Earning Date
11-12-2025
03-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$4,133,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.20
$7.15
52 Week High
$3.23
$17.44

Technical Indicators

Market Signals
Indicator
WRAP
ACET
Relative Strength Index (RSI) 54.58 79.68
Support Level $2.90 $7.70
Resistance Level $3.23 $8.56
Average True Range (ATR) 0.25 0.50
MACD 0.04 0.08
Stochastic Oscillator 58.68 90.54

Price Performance

Historical Comparison
WRAP
ACET

About WRAP Wrap Technologies Inc.

Wrap Technologies Inc is a public safety technology and services company that delivers safe and effective policing solutions to law enforcement and security personnel worldwide. The firm develops policing solutions to law enforcement and security personnel. Its BolaWRAP 150 Remote Restraint device is a patented, hand-held tool that discharges a Kevlar cord to restrain noncompliant individuals from a range of 10-25 feet. The group operates in the Americas, Europe, the Middle East, Africa and the Asia Pacific.

About ACET Adicet Bio Inc.

Adicet Bio Inc is a clinical-stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Its product candidate, ADI-001, a first-in-class allogeneic gamma delta T cell therapy expressing a CAR targeting CD20, is being developed for the potential treatment of autoimmune diseases and relapsed or refractory aggressive B cell non-Hodgkin's lymphoma. Their pipeline also includes its preclinical candidate, ADI-270, an armored gamma delta CAR T cell product candidate targeting renal cell carcinoma, with potential for other CD70+ solid tumor and hematological malignancies indications.

Share on Social Networks: